Changes in clinical trials of endocrine disorder and metabolism and nutrition disorder drugs in mainland China over 2010–2019

With the improvements in relevant policies, laws, and regulations regarding drug clinical trials in China, the quantity and quality of drug clinical trials have gradually improved, and the development prospects of drug clinical trials for endocrine disorders and metabolism and nutrition disorders ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xin, Wu, Suqin, Sun, Jian, Ni, Suiqin, Lu, Laichun, Hu, Wei, Wei, Hua, Zou, Yanqin, Li, Ting, Li, Jintong, Mijiti, Bugela, Fang, PingFei, Zhao, Limei, Zhou, Huan, Xing, Xiaoming, Niu, Haitao, Cao, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931124/
https://www.ncbi.nlm.nih.gov/pubmed/33660404
http://dx.doi.org/10.1002/prp2.729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931124/
https://www.ncbi.nlm.nih.gov/pubmed/33660404
http://dx.doi.org/10.1002/prp2.729

Ejemplares similares